Literature DB >> 21887521

Extrapyramidal syndromes in frontotemporal degeneration.

Andrew Kertesz1, Paul McMonagle, Sarah Jesso.   

Abstract

Descriptions of extrapyramidal (EP) involvement in Pick's disease (renamed recently as FTD) appeared 80 years ago. CBD pathology was confirmed as a common substrate for primary progressive aphasia (PPA). We suggested that CBD and PPA should be included with frontal lobe dementia as Pick complex. PSP was prototype for "subcortical dementia", and aphasia and apraxia, considered unusual for PSP, are now seen as a rule. The overlap of PSP and CBD is considerable. We recently reviewed our cohort with EPS in FTD and identified 22 patients with the movement disorder as a first syndrome and another larger group of 48 patients who developed EPS after an initial onset with a cognitive disorder: aphasic, behavioral or both. All cognitive onset CBD/PSP patients and all but two with motor onset developed aphasia during the course of their illness. General cognitive and behavioral measures are similar for each presentation, but language scores are worse in cognitive onset cases, reflecting the frequency of aphasic presentations. Anomic patients become non-fluent, logopenic, agrammatic and mute. Using the Frontal Behavioral Inventory (FBI), a questionnaire specifically designed for the spectrum of apathy and disinhibition displayed by patients with FTD, we have documented the behavior change in CBD/PSP with motor and cognitive onsets. The significant personality changes consisted of apathy, disinhibition, perseveration and inattention, some of the core symptoms of FTD. In 18 autopsied cases, 15 had tau pathology. The overlap of CBD/PSP with PPA and bvFTD suggests a spectrum of related entities and predicts tau-positive pathology. Cross-sectional studies without significant follow-up may not observe the subsequent development language or behavior deficit, or the evolution from PPA and/or FTD-bv to CBD/PSP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887521     DOI: 10.1007/s12031-011-9616-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

1.  Corticobasal ganglionic degeneration with Balint's syndrome.

Authors:  M F Mendez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

2.  Cortical basal ganglionic degeneration presenting with "progressive loss of speech output and orofacial dyspraxia".

Authors:  A E Lang
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

3.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

Review 4.  Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?

Authors:  Sharon Sha; Craig Hou; Indre V Viskontas; Bruce L Miller
Journal:  Nat Clin Pract Neurol       Date:  2006-12

Review 5.  Apraxia in movement disorders.

Authors:  Cindy Zadikoff; Anthony E Lang
Journal:  Brain       Date:  2005-06-01       Impact factor: 13.501

6.  Corticobasal degeneration and progressive aphasia.

Authors:  Paul McMonagle; Mervin Blair; Andrew Kertesz
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

7.  Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).

Authors:  T H Bak; L M Crawford; V C Hearn; P S Mathuranath; J R Hodges
Journal:  Neurocase       Date:  2005-08       Impact factor: 0.881

8.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

9.  Corticobasal syndrome associated with the A9D Progranulin mutation.

Authors:  Salvatore Spina; Jill R Murrell; Edward D Huey; Eric M Wassermann; Pietro Pietrini; Jordan Grafman; Bernardino Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  2007-10       Impact factor: 3.685

10.  Clinical and pathological characterization of progressive aphasia.

Authors:  Jonathan A Knibb; John H Xuereb; Karalyn Patterson; John R Hodges
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

View more
  15 in total

Review 1.  Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report.

Authors:  Deborah A Hall; Maria João Forjaz; Lawrence I Golbe; Irene Litvan; Christine Ann M Payan; Christopher G Goetz; Albert F G Leentjens; Pablo Martinez-Martin; Anne Pavy-Le Traon; Cristina Sampaio; Bart Post; Glenn Stebbins; Daniel Weintraub; Anette Schrag
Journal:  Mov Disord Clin Pract       Date:  2015-05-22

2.  You don't say: dynamic aphasia, another variant of primary progressive aphasia?

Authors:  David L Perez; Bradford C Dickerson; Scott M McGinnis; Daisy Sapolsky; Keith Johnson; Meghan Searl; Kirk R Daffner
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  Extrapyramidal examinations in psychiatry.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Innov Clin Neurosci       Date:  2012-07

4.  In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology.

Authors:  Francesca Caso; Maria Luisa Mandelli; Maya Henry; Benno Gesierich; Brianne M Bettcher; Jennifer Ogar; Massimo Filippi; Giancarlo Comi; Giuseppe Magnani; Manu Sidhu; John Q Trojanowski; Eric J Huang; Lea T Grinberg; Bruce L Miller; Nina Dronkers; William W Seeley; Maria Luisa Gorno-Tempini
Journal:  Neurology       Date:  2013-12-18       Impact factor: 9.910

5.  Incidence of frontotemporal disorders in Olmsted County: A population-based study.

Authors:  Pierpaolo Turcano; Cole D Stang; Michelle M Mielke; Peter R Martin; Sudhindra G Upadhyaya; Keith A Josephs; Bradley F Boeve; David S Knopman; Ronald C Petersen; Rodolfo Savica
Journal:  Alzheimers Dement       Date:  2020-01-04       Impact factor: 21.566

6.  Motor Speech Disorders Associated with Primary Progressive Aphasia.

Authors:  Joseph R Duffy; Edythe A Strand; Keith A Josephs
Journal:  Aphasiology       Date:  2014-08       Impact factor: 2.773

Review 7.  Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.

Authors:  Rebecca L Wallings; Stewart W Humble; Michael E Ward; Richard Wade-Martins
Journal:  Trends Neurosci       Date:  2019-11-05       Impact factor: 13.837

Review 8.  Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia.

Authors:  Christine Le; Elizabeth Finger
Journal:  CNS Drugs       Date:  2021-08-24       Impact factor: 5.749

9.  Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy.

Authors:  Laura E Hughes; Boyd C P Ghosh; James B Rowe
Journal:  Neuroimage Clin       Date:  2013       Impact factor: 4.881

Review 10.  New perspective on parkinsonism in frontotemporal lobar degeneration.

Authors:  Hee Kyung Park; Sun J Chung
Journal:  J Mov Disord       Date:  2013-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.